AU2013903572A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents

Compositions for the treatment of hypertension and/or fibrosis

Info

Publication number
AU2013903572A0
AU2013903572A0 AU2013903572A AU2013903572A AU2013903572A0 AU 2013903572 A0 AU2013903572 A0 AU 2013903572A0 AU 2013903572 A AU2013903572 A AU 2013903572A AU 2013903572 A AU2013903572 A AU 2013903572A AU 2013903572 A0 AU2013903572 A0 AU 2013903572A0
Authority
AU
Australia
Prior art keywords
fibrosis
hypertension
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013903572A
Inventor
Karen Annette Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Pty Ltd
Original Assignee
Vectus Biosystems Pty Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of AU2013903572A0 publication Critical patent/AU2013903572A0/en
Priority to RU2016112053A priority Critical patent/RU2661878C2/en
Priority to EP14845828.4A priority patent/EP3046902B1/en
Priority to DK14845828.4T priority patent/DK3046902T3/en
Priority to PCT/AU2014/000922 priority patent/WO2015039172A1/en
Priority to UAA201602269A priority patent/UA117254C2/en
Priority to ES14845828.4T priority patent/ES2694375T3/en
Priority to SG11201601641VA priority patent/SG11201601641VA/en
Priority to BR112016005606-0A priority patent/BR112016005606B1/en
Priority to JP2016515427A priority patent/JP6293266B2/en
Priority to AP2016009080A priority patent/AP2016009080A0/en
Priority to MX2016003372A priority patent/MX368011B/en
Priority to CN201480050947.1A priority patent/CN105683153B/en
Priority to MYPI2016000481A priority patent/MY191337A/en
Priority to NZ717930A priority patent/NZ717930A/en
Priority to KR1020167009836A priority patent/KR101863708B1/en
Priority to AU2014324075A priority patent/AU2014324075B2/en
Priority to US15/022,264 priority patent/US9630935B2/en
Priority to CA2924353A priority patent/CA2924353C/en
Priority to PH12016500495A priority patent/PH12016500495B1/en
Priority to IL244622A priority patent/IL244622A0/en
Abandoned legal-status Critical Current

Links

AU2013903572A 2013-09-17 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis Abandoned AU2013903572A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
CA2924353A CA2924353C (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
JP2016515427A JP6293266B2 (en) 2013-09-17 2014-09-17 Composition for the treatment of hypertension and / or fibrosis
CN201480050947.1A CN105683153B (en) 2013-09-17 2014-09-17 composition for treating hypertension and/or fibrosis
DK14845828.4T DK3046902T3 (en) 2013-09-17 2014-09-17 COMPOSITIONS FOR TREATING HYPERTENSION AND / OR FIBROSE
PCT/AU2014/000922 WO2015039172A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
UAA201602269A UA117254C2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
ES14845828.4T ES2694375T3 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and / or fibrosis
SG11201601641VA SG11201601641VA (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
BR112016005606-0A BR112016005606B1 (en) 2013-09-17 2014-09-17 COMPOUND, PHARMACEUTICAL COMPOSITION, AND USES OF A COMPOUND
RU2016112053A RU2661878C2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
AP2016009080A AP2016009080A0 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
MX2016003372A MX368011B (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis.
EP14845828.4A EP3046902B1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
MYPI2016000481A MY191337A (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
NZ717930A NZ717930A (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
KR1020167009836A KR101863708B1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
AU2014324075A AU2014324075B2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
US15/022,264 US9630935B2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
PH12016500495A PH12016500495B1 (en) 2013-09-17 2016-03-14 Compositions for the treatment of hypertension and/or fibrosis
IL244622A IL244622A0 (en) 2013-09-17 2016-03-16 Compositions for the treatment of hypertension and/or fibrosis

Publications (1)

Publication Number Publication Date
AU2013903572A0 true AU2013903572A0 (en) 2013-10-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP2877159B8 (en) Efflux inhibitor compositions and methods of treatment using the same
EP2991658A4 (en) Antimicrobial compositions and methods of making the same
EP3030266A4 (en) Topical compositions and methods of using the same
EP3179983A4 (en) Anti-methanogenic compositions and uses thereof
EP3071215A4 (en) Compositions and methods for treating pulmonary hypertension
EP3102555A4 (en) Compositions of compounds and uses thereof
EP3102200A4 (en) Therapeutic compounds and compositions
EP3021839A4 (en) Methods and compositions for treatment of fibrosis
EP2983681A4 (en) Therapeutic compositions and uses thereof
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3013364A4 (en) Tuberculosis compositions and methods of using the same
EP3004396A4 (en) Methods and compositions for the treatment of cancer
IL244621A (en) Compositions for the treatment of hypertension and/or fibrosis
IL244622A0 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3117827A4 (en) Composition for vagina and use of the composition
PL2968478T3 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3165221A4 (en) Blood-fat reducing composition and application thereof
EP3113774A4 (en) Compositions of grapiprant and methods for using the same
EP3110435A4 (en) Methods and compositions for the delayed treatment of stroke
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
EP3038596A4 (en) Compositions and methods for the removal of tattoos
EP3271320A4 (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3294294A4 (en) Compositions and methods for the treatment or prevention of pulmonary hypertension
EP3068431A4 (en) Methods and compositions for the treatment of hcmv